Castellano, D, Apolo, AB, Porta, C, Capdevila, J, Viteri, S, Rodriguez-Antona, C, Martin, L, Maroto, P. Cabozantinib combination therapy for the treatment of solid tumors: a systematic review. Therapeutic Advances in Medical Oncology. 2022; 14DOI:10.1177/17588359221108691. PMID:35923927. IF:4.900(Q2/4D).

Parra-Perez, AM, Perez-Jimenez, A, Gris-Cardenas, I, Bonel-Perez, GC, Carrasco-Diaz, LM, Mokhtari, K, Garcia-Salguero, L, Lupianez, JA, Rufino-Palomares, EE. Involvement of the PI3K/AKT Intracellular Signaling Pathway in the AntiCancer Activity of Hydroxytyrosol, a Polyphenol from Olea europaea, in Hematological Cells and Implication of HSP60 Levels in Its Anti-Inflammatory Activity. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2022; 23(13)DOI:10.3390/ijms23137053. PMID:35806065. IF:5.600(Q1/3D).

Alvarez-Larran, A, Garrote, M, Ferrer-Marin, F, Perez-Encinas, M, Mata-Vazquez, MI, Bellosillo, B, Arellano-Rodrigo, E, Gomez, M, Garcia, R, Garcia-Gutierrez, V, Gasior, M, Cuevas, B, Angona, A, Gomez-Casares, MT, Martinez, CM, Magro, E, Ayala, R, del Orbe-Barreto, R, Perez-Lopez, R, Fox, ML, Raya, JM, Guerrero, L, Garcia-Hernandez, C, Caballero, G, Murillo, I, Xicoy, B, Ramirez, MJ, Carreno-Tarragona, G, Hernandez-Boluda, JC, Pereira, A. Real-world analysis of main clinical outcomes in patients with polycythemia vera treated with ruxolitinib or best available therapy after developing resistance/intolerance to hydroxyurea. CANCER. 2022; 128(13)DOI:10.1002/cncr.34195. PMID:35417564. IF:6.200(Q1/3D).

Lop, J, Venegas, MD, Pujol, A, Sauter, B, Vasquez, R, Casasayas, M, Quer, M, Leon, X. Causes of long-term mortality in patients with head and neck squamous cell carcinomas. EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY. 2022; 279(7)DOI:10.1007/s00405-021-07211-8. PMID:34905065. IF:2.600(Q2/3D).

Leon, X, Garcia, J, Pujol, A, de Juan, J, Vasquez, R, Quer, M, Camacho, M. Relationship between the transcriptional expression of PIM1 and local control in patients with head and neck squamous cell carcinomas treated with radiotherapy. EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY. 2022; 279(7)DOI:10.1007/s00405-021-07223-4. PMID:34993612. IF:2.600(Q2/3D).

Alonso, LG, Aizpurua, DA, Alvarez, XM, Serra, LA, Sanabria, MT, Li, CH. Percutaneous closure of left ventricular pseudoaneurysm. Case resolution. REC, interventional cardiology. 2022; 4(3)DOI:10.24875/RECICE.M22000285. PMID:. IF:(Q/D).

Alonso, LG, Aizpurua, DA, Alvarez, XM, Serra, LA, Sanabria, MT, Li, CH. Percutaneous closure of left ventricular pseudoaneurysm. REC, interventional cardiology. 2022; 4(3)DOI:10.24875/RECICE.M22000284. PMID:. IF:(Q/D).

Mazuecos, A, Villanego, F, Zarraga, S, Lopez, V, Oppenheimer, F, Llinas-Mallol, L, Hernandez, AM, Rivas, A, Ruiz-Fuentes, MC, Toapanta, NG, Jimenez, C, Cabello, S, Beneyto, I, Aladren, MJ, Rodriguez-Benot, A, Canal, C, Molina, M, Perez-Flores, I, Saura, IM, Gavela, E, Franco, A, Lorenzo, I, Galeano, C, Tabernero, G, Perez-Tamajon, L, Martin-Moreno, PL, Fernandez-Giron, F, Siverio, O, Labrador, PJ, De Arriba, G, Simal, F, Cruzado, L, Moina, I, Alcalde, G, Sanchez-Alvarez, E, Pascual, J, Crespo, M. Breakthrough Infections Following mRNA SARS-CoV-2 Vaccination in Kidney Transplant Recipients. TRANSPLANTATION. 2022; 106(7)DOI:10.1097/TP.0000000000004119. PMID:35384924. IF:6.200(Q1/1D).